Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Column

A Framework for Person-Centered Care Pathways in Oncology
PATIENT PERSPECTIVE
A Framework for Person-Centered Care Pathways in Oncology
02/18/2020
Alan Balch, PhD—Column Editor
Historically, the development of clinical pathways has been effective in treatment planning for cancer care. In line with the increasing sophistication of pathways, it is time to consider how patient-specific factors...
Historically, the development of clinical pathways has been effective in treatment planning for cancer care. In line with the increasing sophistication of pathways, it is time to consider how patient-specific factors...
...
02/18/2020
Journal of Clinical Pathways

Advertisement

Counterpoint
Are We Really Measuring Quality?
12/17/2019
Winston Wong, PharmD, Editor-in-Chief
Dr Wong responds to the Viewpoint by Dr Valuck and colleagues, contemplating and evaluating the current quality measures used in care today. He asserts that, rather than trying to develop, revise, and modify quality...
Dr Wong responds to the Viewpoint by Dr Valuck and colleagues, contemplating and evaluating the current quality measures used in care today. He asserts that, rather than trying to develop, revise, and modify quality...
Dr...
12/17/2019
Journal of Clinical Pathways
Viewpoint
Catch Me If You Can: Aligning Quality Measurement With Oncology Innovation
12/17/2019
Tom Valuck, MD, JD—Blog Editor
David Blaisdell
Theresa Schmidt, MA
Breakthrough treatments in cancer care, including precision therapies tailored to specific patient factors, are driving rapid changes in the definitions of oncology quality and value. Efforts to implement value-based...
Breakthrough treatments in cancer care, including precision therapies tailored to specific patient factors, are driving rapid changes in the definitions of oncology quality and value. Efforts to implement value-based...
...
12/17/2019
Journal of Clinical Pathways
Business of Pathways
Health Care as a Preexisting Financial Condition: Individual Costs and Societal Benefits
12/17/2019
Sean McElligott, MS
Ira Klein, MD, MBA, FACP—Column Editor
While societally we are still debating the best way to finance health care, we do all agree that when a  therapy is available to alleviate illness and suffering, we should find a way to make it available to patients....
While societally we are still debating the best way to finance health care, we do all agree that when a  therapy is available to alleviate illness and suffering, we should find a way to make it available to patients....
While...
12/17/2019
Journal of Clinical Pathways

Advertisement

Trending From ACCC
Susan Dentzer to Address Disruptive Innovations and the Future of Cancer Care at ACCC 46th Annual Meeting & Cancer Center Business Summit
12/17/2019
JCP Editors
This spring, the Association of Community Cancer Centers (ACCC) is excited to feature Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy, at the ACCC 46th Annual Meeting & Cancer...
This spring, the Association of Community Cancer Centers (ACCC) is excited to feature Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy, at the ACCC 46th Annual Meeting & Cancer...
This...
12/17/2019
Journal of Clinical Pathways
Editor's Page
Measuring Quality, Improving Care Delivery
12/17/2019
Winston Wong, PharmD, Editor-in-Chief
In value-based payment models, cost-containment incentives must be counterbalanced by quality measures to ensure that patients are not denied access to appropriate yet potentially costly care. Quality measures are...
In value-based payment models, cost-containment incentives must be counterbalanced by quality measures to ensure that patients are not denied access to appropriate yet potentially costly care. Quality measures are...
In...
12/17/2019
Journal of Clinical Pathways
Clinical Pathways GPS
Speaker Pelosi’s Plan to Lower Drug Costs
11/18/2019
Matthew Pakizegee, PharmD, MS
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
As total cost of care increasingly becomes a major issue in the United States, both market solutions like clinical pathways and government solutions such as drug pricing regulations are being proposed. Each solution...
As total cost of care increasingly becomes a major issue in the United States, both market solutions like clinical pathways and government solutions such as drug pricing regulations are being proposed. Each solution...
As...
11/18/2019
Journal of Clinical Pathways

Advertisement

Pharma Insights
How Development of Gene Therapies Impact Decisions on Their Place in Therapy
11/18/2019
Larry Blandford, PharmD—Column Editor
Aaron Burke
Gene therapy has sparked significant interest among researchers, health care providers, and patients because it offers the tantalizing possibility of a cure, particularly for rare diseases with a genetic basis. While...
Gene therapy has sparked significant interest among researchers, health care providers, and patients because it offers the tantalizing possibility of a cure, particularly for rare diseases with a genetic basis. While...
Gene...
11/18/2019
Journal of Clinical Pathways
Trending From ACCC
ACCC Spotlights Strategies to Improve Care for Senior Adults With Cancer
11/18/2019
JCP Editors
By 2030, it is estimated that 70% of cancers in the United States will be diagnosed in older adults, and by 2040 nearly three-fourths (73%) of the country’s cancer survivors will be aged 65 years or older.1,2 This...
By 2030, it is estimated that 70% of cancers in the United States will be diagnosed in older adults, and by 2040 nearly three-fourths (73%) of the country’s cancer survivors will be aged 65 years or older.1,2 This...
By...
11/18/2019
Journal of Clinical Pathways
Editor's Page
More Comprehensive Pathways to Support Success in Value-Based Reimbursement Models
11/18/2019
Winston Wong, PharmD, Editor-in-Chief
Clinical pathways—defined as structured, multidisciplinary care plans that incorporate evidence-based guidelines and protocols to standardize care—represent a natural strategy for achieving success in the Oncology...
Clinical pathways—defined as structured, multidisciplinary care plans that incorporate evidence-based guidelines and protocols to standardize care—represent a natural strategy for achieving success in the Oncology...
...
11/18/2019
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use